Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

It seems demand is growing amongst women in perimenopause, menopause and postmenopause looking for multifaceted weight loss ...

I’m holding my Ozempic pen, a prefilled injection containing the active ingredient semaglutide, and trying to remember how ...

Vivani Medical completed enrollment in its LIBERATE-1 trial, testing a six-month GLP-1 implant for weight management.

Novo Nordisk announced updates to the Wegovy® savings program, allowing all eligible cash-paying patients access to Wegovy® (semaglutide) injection 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg at their ...

I’ve also been spacing out the 1mg dosages for a while ... Is low-dose Ozempic a good way to maintain weight loss for the foreseeable future? Or else, I could just use it liberally, as and ...

Now, thanks to social media, microdosing has spread into the mainstream use of prescribed medications, most notably with weight-loss injections ... and cutting down to 0.1mg – or simply ...